Galmed Pharmaceuticals Ltd. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Sept. 20, 2024).

Předmět:	PHARMACEUTICAL biotechnology industry BIOTECHNOLOGY industries INDUSTRY classification PUBLIC companies LAW offices
Zdroj:	Pharma Business Week; 10/10/2024, p1625-1625, 1p
Abstrakt:	Galmed Pharmaceuticals Ltd., a biopharmaceutical company, has filed a Form SC 13G/A with the U.S. Securities and Exchange Commission (SEC). The filing, made on September 20, 2024, is a formal document or financial statement submitted by publicly-traded companies. The contact information for Galmed Pharmaceuticals Ltd. is provided in the filing. For more information on the filing, readers can visit the SEC's website. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu